ULTROMICS
They are building world-class diagnostic aids to help cardiologists โ powered by artificial intelligence. To date, they have developed the worldโs most accurate echocardiography software to improve the diagnosis of coronary heart disease by more than 90%.
ULTROMICS
Industry:
Artificial Intelligence (AI) Computer Vision Health Care Health Diagnostics Medical Software
Founded:
2017-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.ultromics.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
58.82 M USD
Technology used in webpage:
Google Maps Amazon Apple Mobile Web App Capable Amazon Virginia Region Microsoft CloudFront Apple Mobile Web App Status Bar Style HSTS IncludeSubdomains PreLoad Amazon SSL Microsoft Azure
Similar Organizations
5C Network
5C is India's first Diagnostics Network, making Radiodiagnosis more Accessible, Affordable and Accurate
AZmed
AZmed is a Medtech startup that offers innovative solutions to optimize healthcare specialistsโ workflow by using AI.
Infervision
Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.
Iterative Scopes
Iterative Scopes delivers tools for physicians and life sciences in colorectal cancer and inflammatory bowel disease space.
Petuum
Petuum, Inc. is building a platform that serves the full spectrum of Artificial Intelligence
Powerful Medical
Powerful Medical provides AI solutions that enable medical professionals to accurately diagnose and treat cardiovascular disease.
Proximie
Proximie is a health technology platform that enables surgeons to virtually attend operating theaters to visually guide complex surgeries.
Scailyte
True precision medicine through single-cell science
TORTUS AI
TORTUS AI creates and operates an online tool using artificial intelligence for the healthcare industry.
Current Employees Featured
Founder
Investors List
Oxford Science Enterprises
Oxford Science Enterprises investment in Series B - Ultromics
Google Ventures
Google Ventures investment in Series B - Ultromics
Optum Ventures
Optum Ventures investment in Series B - Ultromics
The Blue Venture Fund
The Blue Venture Fund investment in Series B - Ultromics
Nina Capital
Nina Capital investment in Series A - Ultromics
Future Planet Capital
Future Planet Capital investment in Venture Round - Ultromics
RT Ventures
RT Ventures investment in Series A - Ultromics
Andre Crawford-Brunt
Andre Crawford-Brunt investment in Series A - Ultromics
GT Healthcare Capital Partners
GT Healthcare Capital Partners investment in Series A - Ultromics
Fushia Investments
Fushia Investments investment in Series A - Ultromics
Official Site Inspections
http://www.ultromics.com Semrush global rank: 4.11 M Semrush visits lastest month: 2.53 K
- Host name: 172.67.75.135
- IP address: 172.67.75.135
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ultromics"
Next-generation Echocardiography is here - Ultromics
Ultromics' algorithms are trained on 10 years of outcome data to reliably recognize suspicious echocardiograms. The algorithms automatically analyzes studies, identifies disease, and โฆSee details»
Ultromics - Crunchbase Company Profile & Funding
Organization. Ultromics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Ultromics clinicians and engineers working together to set new standards for world-class โฆSee details»
About - Why Ultromics? - Ultromics
Ultromics was born at the University of Oxford from leading minds in science and AI, built in partnership with the U.K.โs NHS, and is now government backed, raised over £35 million - with the likes of Blues Ventures, Optum, and Google โฆSee details»
Ultromics Company Profile 2024: Valuation, Funding & Investors
Ultromics was founded in 2017. Where is Ultromics headquartered? Ultromics is headquartered in Oxford, United Kingdom. What is the size of Ultromics? Ultromics has 66 total employees. โฆSee details»
Ultromics - Overview, News & Similar companies | ZoomInfo.com
Ultromics Announces Partnership to Expedite Development of Echo AI Algorithm for Early Detection of Cardiac Amyloidosis OXFORD, England, Jan. 10, 2024 /PRNewswire/ -- โฆSee details»
Ultromics - LinkedIn
Ultromics pioneers precision heart failure detection. Our groundbreaking platform, EchoGo®, is revolutionizing the diagnosis of heart failure using artificial intelligence and cardiac ultrasound.See details»
Ultromics Company Profile - Office Locations, Competitors, โฆ
Ultromics has 5 employees across 3 locations, $26.03 m in total funding, and £594.8 k in annual revenue in FY 2021. See insights on Ultromics including office locations, competitors, revenue, โฆSee details»
Ultromics - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors ... Unlock for free . Nov 1, 2019: Venture Round - Ultromics . 1: โฆSee details»
Ultromics Raises $33M in Series B Funding to Help Transform โฆ
Aug 16, 2021 Oxford Sciences Innovation, an organization that helps scientific breakthroughs become world-changing businesses, helped get Ultromics' business off the ground, and โฆSee details»
Ultromics - Oxford Science Enterprises
All Company News 09โข01โข24 Portfolio News Ultromics announces partnership to expedite development of Echo AI algorithm 07โข11โข23 Portfolio News CMS publishes final Clinical APC rule for Ultromics EchoGo® Heart Failure โฆSee details»
About - Team - Ultromics
Ultromics was born at the University of Oxford from leading minds in science and AI, built-in partnership with the U.Kโs NHS, and our team include world leading experts like Dr. Patricia A. โฆSee details»
Ultromics CEO and Key Executive Team | Craft.co
Ultromics's Founder and Chief Executive Officer is Ross Upton. Other executives include Paul Leeson, Founder and Chief Medical Officer; Helen Routh, Non-Executive Director and 11 โฆSee details»
Ultromics - Contacts, Employees, Board Members, Advisors
Ultromics clinicians and engineers working together to set new standards for world-class cardiovascular diagnostic tools.See details»
Ultromics racks up $33M to drive its cardiac ultrasound AI software
Aug 16, 2021 The funding will also help Ultromics pitch its offerings for clinical studies, which may currently rely on more expensive and less accurate imaging technologies, co-founder and โฆSee details»
Ultromics Announces Partnership to Expedite Development of โฆ
Jan 10, 2024 Ultromics is a pioneer in precision heart failure detection. Our ground-breaking platform, EchoGo®, is transforming the way heart failure is diagnosed using artificial โฆSee details»
Ultromics obtains Breakthrough Device FDA clearance for its โฆ
Nov 20, 2024 Ultromics' EchoGo® Amyloidosis, clinical AI for echocardiography with the potential to revolutionize early detection of Cardiac Amyloidosis, has received US Food and โฆSee details»
Partners - Ultromics
This is why Ultromics was thrilled to work with Microsoft to implement its AI service on the Microsoft Azure Marketplace. This online store provides certified software applications and โฆSee details»
Careers - Ultromics
At Ultromics, we believe that diversity drives innovation and success. We are proud to be an equal opportunities employer, dedicated to creating a welcoming and inclusive environment for all. โฆSee details»
Get in touch - Ultromics
Get in touch. We look forward to showing you how you can reach a new level of confidence in heart failure diagnosis with our echocardiography platformSee details»